The investigators observed these cells in the bone marrow of individuals with acute disseminated lupus erythematosus and postulated that the cell “...is the result of...phagocytosis of free nuclear ...

One of Merck KGaA’s leading immunology assets has flunked a phase 2 lupus trial. | One of Merck KGaA’s leading immunology ...

Chimeric antigen receptor T-cell therapy improves not only lupus disease activity but also other related conditions that ...

Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...

Lupus is an autoimmune disease where the body’s immune system attacks its own tissues and organs, causing inflammation and damaging organs.

For patients with systemic lupus erythematosus (SLE) and pericarditis, recurrence of pericarditis occurs in more than 20% of patients and associated factors include younger age, prednisone treatment, ...

In standing together, we can ensure that Mercédi’s fight with lupus is not her fight alone. A community mobilised by empathy ...

Subcategories are pooled on. NPSLE: Neuropsychiatric systemic lupus erythematosus; NR: Not reported. Table 2. Summary of the relationship between the type of pathogenic event, putative ...

The REGENCY trial enrolled 271 patients with systemic lupus erythematosus and active class ... gastroenteritis, and acute kidney injury. There were three deaths in the obinutuzumab group including ...